PRESS RELEASE published on 02/06/2026 at 11:45, 4 months 11 days ago Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros Board of Directors of Sartorius Stedim Biotech S.A. resolves dividend proposal of 0.69 euros for fiscal 2025, with total distributed profit of 67.1 million euros. Annual Shareholders' Meeting scheduled for March 24, 2026 Board Of Directors Financial Results Dividend Proposal Sartorius Stedim Biotech Annual Shareholders' Meeting
BRIEF published on 02/03/2026 at 07:20, 4 months 14 days ago Sartorius Stedim Biotech is recording significant growth in 2025 EBITDA Revenue Sartorius Stedim Biotech Growth 2025 Consumables
BRIEF published on 02/03/2026 at 07:05, 4 months 14 days ago Sartorius Stedim Biotech records strong growth in 2025 EBITDA Biotechnology Sartorius Growth 2025 Consumables
PRESS RELEASE published on 02/03/2026 at 07:00, 4 months 14 days ago Sartorius Stedim Biotech achieves considerable profitable growth in 2025 and maintains positive outlook Sartorius Stedim Biotech achieves significant profitable growth in 2025 with unaudited sales revenue up 9.6% in constant currencies. Management expects continued growth in 2026 Financial Results Sartorius Stedim Biotech Profitable Growth 2025 2026
BRIEF published on 02/02/2026 at 14:01, 4 months 15 days ago Sartorius Stedim Biotech Discloses Share and Voting Rights Structure Voting Rights Sartorius Stedim Biotech Regulatory Disclosure Issued Capital Share Structure
BRIEF published on 02/02/2026 at 14:01, 4 months 15 days ago Statement of Share Capital of Sartorius Stedim Biotech SA as of January 31, 2026 Share Capital Voting Rights AMF Aubagne Sartorius Stedim
PRESS RELEASE published on 02/02/2026 at 13:57, 4 months 15 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech S.A. declares the number of shares and voting rights. Details include total shares, theoretical voting rights, and net voting rights Voting Rights Capital Shares Sartorius Stedim Biotech France
PRESS RELEASE published on 02/02/2026 at 13:56, 4 months 15 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA declares the number of shares and voting rights comprising the issued capital, as of Jan 31, 2026 Voting Rights Shares Sartorius Stedim Biotech Regulatory Announcement Issued Capital
BRIEF published on 01/06/2026 at 10:28, 5 months 11 days ago Sartorius Stedim Biotech: Half-Year Liquidity Statement Liquidity Contract Kepler Cheuvreux Market Practice Biotech Industry Sartorius Stedim Biotech
BRIEF published on 01/06/2026 at 10:28, 5 months 11 days ago Sartorius Stedim Biotech Liquidity Contract Review Liquidity Contract Transactions Kepler Cheuvreux Sartorius Stedim Biotech Financial Resources
Published on 06/17/2026 at 14:30, 2 hours 14 minutes ago Solitario Advances 2026 Ponderosa Drilling Program
Published on 06/17/2026 at 14:00, 2 hours 44 minutes ago CHAR Tech Reminds Shareholders of June 18 Investor Update Call
Published on 06/17/2026 at 14:00, 2 hours 44 minutes ago Interpretation of High-Resolution Geophysics at Music Valley HREE Project
Published on 06/17/2026 at 14:00, 2 hours 44 minutes ago AEONIAN Completes Drilling at Jake Target and Advances District-Scale Copper-Silver Model, Koocanusa Project, BC
Published on 06/17/2026 at 15:54, 49 minutes ago CANCOM SE: Annual General Meeting approves all proposed resolutions by a large majority
Published on 06/17/2026 at 15:38, 1 hour 5 minutes ago United Terra Enterprises PLC Expands Renewable Portfolio via Strategic Alternative Energy Joint Venture Company in Ghana
Published on 06/17/2026 at 08:45, 7 hours 59 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 4 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 1 day 17 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 1 day 21 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026
Published on 06/15/2026 at 18:32, 1 day 22 hours ago Edenred strengthens its electric charging offering with the acquisition of The Mobility House Solutions